生物制剂-话题@MedSci

#生物制剂#

123篇内容 | 5349人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1825964, encodeId=336818259641c, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂tildrakizumab：牛皮癣“克星”, objectType=article, longId=101036, objectId=ea8210103664, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea8210103664, replyNumber=0, likeNumber=73, createdTime=2018-03-14, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea8210103664, moduleTitle=生物制剂tildrakizumab：牛皮癣“克星”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea8210103664)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825957, encodeId=5046182595e6f, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=JAMA Dermatol：生物制剂可减少银屑病患者的冠状动脉疾病进展, objectType=article, longId=72959, objectId=22ebe295900, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22ebe295900, replyNumber=0, likeNumber=82, createdTime=2016-07-16, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22ebe295900, moduleTitle=JAMA Dermatol：生物制剂可减少银屑病患者的冠状动脉疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22ebe295900)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825958, encodeId=8829182595819, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2016BSR/BHPR指南——生物制剂治疗中轴脊椎关节炎（包括强制性脊柱炎）发布, objectType=article, longId=76149, objectId=b082e61491a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b082e61491a, replyNumber=0, likeNumber=0, createdTime=2017-05-05, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b082e61491a, moduleTitle=2016BSR/BHPR指南——生物制剂治疗中轴脊椎关节炎（包括强制性脊柱炎）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b082e61491a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825954, encodeId=4515182595438, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=RA患者不同生物制剂的住院感染风险是否不同？, objectType=article, longId=65003, objectId=1bc4650034d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bc4650034d, replyNumber=0, likeNumber=0, createdTime=2016-06-06, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bc4650034d, moduleTitle=RA患者不同生物制剂的住院感染风险是否不同？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bc4650034d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825956, encodeId=324c1825956bb, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=突破药丸：生物制剂新时代的致胜给药战略, objectType=article, longId=71401, objectId=73dfe140155, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73dfe140155, replyNumber=0, likeNumber=74, createdTime=2016-12-08, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73dfe140155, moduleTitle=突破药丸：生物制剂新时代的致胜给药战略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73dfe140155)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825960, encodeId=5c31182596063, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=JAMA：对TNFα抑制剂反应不足的类风湿性关节炎患者或可选择非TNF生物制剂, objectType=article, longId=78345, objectId=2e99e834555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e99e834555, replyNumber=0, likeNumber=85, createdTime=2017-01-22, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e99e834555, moduleTitle=JAMA：对TNFα抑制剂反应不足的类风湿性关节炎患者或可选择非TNF生物制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e99e834555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825961, encodeId=ad01182596156, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=赛诺菲与喜康生物在华结成生物制剂战略联盟伙伴关系, objectType=article, longId=83610, objectId=6c148361062, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c148361062, replyNumber=0, likeNumber=85, createdTime=2017-04-15, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c148361062, moduleTitle=赛诺菲与喜康生物在华结成生物制剂战略联盟伙伴关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c148361062)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825959, encodeId=b9851825959a7, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Lancet：类风湿性关节炎生物制剂初始治疗：利妥昔单抗or TNF抑制剂？, objectType=article, longId=78325, objectId=ce07e832592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce07e832592, replyNumber=0, likeNumber=83, createdTime=2017-03-04, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce07e832592, moduleTitle=Lancet：类风湿性关节炎生物制剂初始治疗：利妥昔单抗or TNF抑制剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce07e832592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825955, encodeId=05c0182595544, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂在风湿病中的应用, objectType=article, longId=69171, objectId=3c34691e189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c34691e189, replyNumber=0, likeNumber=107, createdTime=2016-08-17, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c34691e189, moduleTitle=生物制剂在风湿病中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c34691e189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825953, encodeId=1db41825953c5, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=全球生物制剂拐点：重磅生物药如何应对生物类似药的竞争, objectType=article, longId=40987, objectId=458d4098e7b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=458d4098e7b, replyNumber=0, likeNumber=68, createdTime=2015-04-27, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=458d4098e7b, moduleTitle=全球生物制剂拐点：重磅生物药如何应对生物类似药的竞争, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=458d4098e7b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825952, encodeId=74941825952fd, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=EULAR指南新增一线生物制剂类风关治疗迎来新希望, objectType=article, longId=31147, objectId=e9353114e55, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9353114e55, replyNumber=0, likeNumber=109, createdTime=2014-12-21, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9353114e55, moduleTitle=EULAR指南新增一线生物制剂类风关治疗迎来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9353114e55)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825951, encodeId=2f1f182595132, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Ann Rheum Dis：论已发表的生物制剂治疗RA的多元治疗比较meta分析之间的差异, objectType=article, longId=24631, objectId=bf2e246314a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf2e246314a, replyNumber=0, likeNumber=77, createdTime=2014-06-03, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf2e246314a, moduleTitle=Ann Rheum Dis：论已发表的生物制剂治疗RA的多元治疗比较meta分析之间的差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf2e246314a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825949, encodeId=c9451825949b8, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Int Med News：重视生物制剂对狼疮的作用, objectType=article, longId=18449, objectId=508c1844919, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508c1844919, replyNumber=0, likeNumber=60, createdTime=2014-04-01, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508c1844919, moduleTitle=Int Med News：重视生物制剂对狼疮的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508c1844919)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825950, encodeId=276118259505f, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=NEJM：生物制剂与常规治疗急性类风湿性关节炎的效果相似, objectType=article, longId=20384, objectId=fc4b203847e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc4b203847e, replyNumber=0, likeNumber=93, createdTime=2014-05-02, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc4b203847e, moduleTitle=NEJM：生物制剂与常规治疗急性类风湿性关节炎的效果相似, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc4b203847e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825948, encodeId=085e182594884, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Ann Rheum Dis :换用生物制剂治疗JIA疗效更小, objectType=article, longId=17049, objectId=23161e0499b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23161e0499b, replyNumber=0, likeNumber=88, createdTime=2014-02-08, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23161e0499b, moduleTitle=Ann Rheum Dis :换用生物制剂治疗JIA疗效更小, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23161e0499b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825946, encodeId=84e81825946ba, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Lancet Oncol：阿瑞吡坦对生物制剂所致严重瘙痒治疗有效, objectType=article, longId=10026, objectId=66f0100260a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66f0100260a, replyNumber=0, likeNumber=73, createdTime=2013-05-30, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66f0100260a, moduleTitle=Lancet Oncol：阿瑞吡坦对生物制剂所致严重瘙痒治疗有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66f0100260a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825945, encodeId=476918259459a, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=JAMA：抗风湿生物制剂或不增加恶性肿瘤风险, objectType=article, longId=9635, objectId=7fc0963527, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fc0963527, replyNumber=0, likeNumber=88, createdTime=2012-09-13, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fc0963527, moduleTitle=JAMA：抗风湿生物制剂或不增加恶性肿瘤风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fc0963527)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825947, encodeId=11a0182594e72, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=FDA批准第一个治疗类风湿关节炎口服生物制剂Xeljanz, objectType=article, longId=11176, objectId=eb2b111e6b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb2b111e6b2, replyNumber=0, likeNumber=74, createdTime=2012-12-10, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb2b111e6b2, moduleTitle=FDA批准第一个治疗类风湿关节炎口服生物制剂Xeljanz, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb2b111e6b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生物制剂

2020-05-29发表于威斯康星

bluefate121

#生物制剂#

生物制剂tildrakizumab：牛皮癣“克星”

2018-03-14

bluefate121

#生物制剂#

JAMA Dermatol：生物制剂可减少银屑病患者的冠状动脉疾病进展

2016-07-16

bluefate121

#生物制剂#

2016BSR/BHPR指南——生物制剂治疗中轴脊椎关节炎（包括强制性脊柱炎）发布

2017-05-05

仁医06

#生物制剂#

RA患者不同生物制剂的住院感染风险是否不同？

2016-06-06

bluefate121

#生物制剂#

突破药丸：生物制剂新时代的致胜给药战略

2016-12-08

bluefate121

#生物制剂#

JAMA：对TNFα抑制剂反应不足的类风湿性关节炎患者或可选择非TNF生物制剂

2017-01-22

bluefate121

#生物制剂#

赛诺菲与喜康生物在华结成生物制剂战略联盟伙伴关系

2017-04-15

bluefate121

#生物制剂#

Lancet：类风湿性关节炎生物制剂初始治疗：利妥昔单抗or TNF抑制剂？

2017-03-04

bluefate121

#生物制剂#

生物制剂在风湿病中的应用

2016-08-17

bluefate121

#生物制剂#

全球生物制剂拐点：重磅生物药如何应对生物类似药的竞争

2015-04-27

bluefate121

#生物制剂#

EULAR指南新增一线生物制剂类风关治疗迎来新希望

2014-12-21

bluefate121

#生物制剂#

Ann Rheum Dis：论已发表的生物制剂治疗RA的多元治疗比较meta分析之间的差异

2014-06-03

智智灵药

#生物制剂#

Int Med News：重视生物制剂对狼疮的作用

2014-04-01

bluefate121

#生物制剂#

NEJM：生物制剂与常规治疗急性类风湿性关节炎的效果相似

2014-05-02

智智灵药

#生物制剂#

Ann Rheum Dis :换用生物制剂治疗JIA疗效更小

2014-02-08

智智灵药

#生物制剂#

Lancet Oncol：阿瑞吡坦对生物制剂所致严重瘙痒治疗有效

2013-05-30

智智灵药

#生物制剂#

JAMA：抗风湿生物制剂或不增加恶性肿瘤风险

2012-09-13

智智灵药

#生物制剂#

FDA批准第一个治疗类风湿关节炎口服生物制剂Xeljanz

2012-12-10